Judy W M Cheng Selected Research

Judy W M Cheng Research Topics

Disease

18	Heart Failure 01/2021 - 03/2002
9	Stroke (Strokes) 01/2019 - 12/2010
9	Myocardial Infarction 01/2019 - 06/2002
8	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 03/2002
6	Atrial Fibrillation 01/2017 - 04/2008
6	Hemorrhage 05/2015 - 03/2002
6	Hypertension (High Blood Pressure) 05/2013 - 03/2002
4	Headache (Headaches) 06/2012 - 01/2005
3	Acute Coronary Syndrome 11/2013 - 12/2010
3	Bradycardia 04/2013 - 03/2009
3	Thrombosis (Thrombus) 12/2010 - 11/2002
3	Hypercholesterolemia 09/2004 - 03/2002
2	Heart Diseases (Heart Disease) 01/2017 - 10/2006
2	ST Elevation Myocardial Infarction 05/2015 - 11/2013
2	Coronary Artery Disease (Coronary Atherosclerosis) 11/2013 - 12/2006
2	Hypotension (Low Blood Pressure) 04/2013 - 01/2005
2	Dyspnea (Shortness of Breath) 06/2012 - 03/2003
2	Venous Thromboembolism 04/2012 - 11/2002
2	Left Ventricular Dysfunction 12/2010 - 10/2009
2	Dizziness (Lightheadedness) 03/2009 - 12/2006
2	Asthma (Bronchial Asthma) 03/2009 - 03/2008
2	Pulmonary Arterial Hypertension 05/2008 - 03/2003
2	Constipation 05/2008 - 12/2006
2	Nausea 12/2006 - 01/2005
2	Homozygous Familial Hypercholesterolemia 09/2004 - 09/2003
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Chronic Renal Insufficiency 01/2021
1	COVID-19 01/2020
1	Severe Acute Respiratory Syndrome 01/2020
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 05/2015
1	Peripheral Arterial Disease 05/2015
1	Ischemia 05/2015
1	Infarction (Infarctions) 11/2013
1	Unstable Angina 11/2013
1	Essential Hypertension 05/2013

Drug/Important Bio-Agent (IBA)

4	Clopidogrel (Plavix)FDA Link 05/2015 - 12/2010
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2015 - 12/2010
3	Angiotensin Receptor AntagonistsIBA 05/2013 - 12/2010
2	alogliptinIBA 01/2019 - 01/2017
2	empagliflozinIBA 01/2019 - 01/2017
2	Sitagliptin Phosphate (Januvia)FDA Link 01/2019 - 01/2017
2	Exenatide (Byetta)FDA Link 01/2019 - 01/2017
2	lixisenatideIBA 01/2019 - 01/2017
2	dapagliflozinIBA 01/2019 - 01/2017
2	dulaglutideIBA 01/2019 - 01/2017
2	Liraglutide FDA Link 01/2019 - 01/2017
2	LinagliptinIBA 01/2019 - 01/2017
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2019 - 01/2017
2	saxagliptin FDA Link 01/2019 - 01/2017
2	CanagliflozinIBA 01/2019 - 01/2017
2	Insulin (Novolin)FDA Link 01/2017 - 06/2002
2	AnticoagulantsIBA 01/2017 - 05/2010
2	TicagrelorIBA 11/2013 - 06/2012
2	Prasugrel Hydrochloride FDA Link 11/2013 - 12/2010
2	azilsartanIBA 05/2013 - 11/2011
2	Enoxaparin (Lovenox)FDA LinkGeneric 04/2012 - 11/2002
2	Digoxin (Digitek)FDA LinkGeneric 12/2010 - 10/2010
2	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 12/2010 - 10/2010
2	Vasodilator Agents (Vasodilators)IBA 12/2010 - 05/2006
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2010 - 10/2009
2	Mineralocorticoid Receptor AntagonistsIBA 12/2010 - 10/2009
2	EnzymesIBA 03/2010 - 03/2009
2	Hydralazine (Apresoline)FDA LinkGeneric 10/2009 - 05/2006
2	NitratesIBA 10/2009 - 05/2006
2	Fish OilsIBA 10/2008 - 03/2002
2	Glucose (Dextrose)FDA LinkGeneric 12/2006 - 06/2002
2	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2005 - 05/2002
2	Endothelins (Endothelin)IBA 01/2005 - 03/2003
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2004 - 09/2003
2	CholesterolIBA 09/2004 - 03/2002
2	oxidized low density lipoproteinIBA 09/2004 - 09/2003
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2021
1	Sodium-Glucose Transport ProteinsIBA 01/2021
1	Angiotensin-Converting Enzyme 2IBA 01/2020
1	semaglutideIBA 01/2019
1	glimepiride (Amarel)FDA LinkGeneric 01/2017
1	Pioglitazone (Actos)FDA Link 01/2017
1	rGLP-1 proteinIBA 01/2017
1	miglitol (Glyset)FDA Link 01/2017
1	Rosiglitazone (Avandia)FDA Link 01/2017
1	meglitinideIBA 01/2017
1	pramlintide (Symlin)FDA Link 01/2017
1	Bromocriptine (Parlodel)FDA LinkGeneric 01/2017
1	Glipizide (Glucotrol)FDA LinkGeneric 01/2017
1	Metformin (Glucophage)FDA LinkGeneric 01/2017
1	Acarbose FDA LinkGeneric 01/2017
1	Glyburide (Glibenclamide)FDA LinkGeneric 01/2017
1	DiureticsIBA 11/2016
1	vorapaxarIBA 05/2015
1	Glycoproteins (Glycoprotein)IBA 11/2013
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 11/2013
1	olmesartanIBA 05/2013
1	Irbesartan FDA LinkGeneric 05/2013
1	Telmisartan (Micardis)FDA Link 05/2013

Therapy/Procedure

11	Therapeutics 01/2020 - 08/2002
4	Drug Therapy (Chemotherapy) 10/2009 - 03/2002
2	Stents 12/2010 - 05/2004
1	Glycemic Control 01/2019
1	Secondary Prevention 05/2015
1	Percutaneous Coronary Intervention 11/2013